Case Report
PDF EndNote BibTex RIS Cite

Year 2021, Volume 3, Issue 1, 45 - 49, 28.02.2021

Abstract

References

  • [1] Wilke T, Groth A, Mueller S, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Eurospace. 2012; 15(4): 486-93. PMid:23220354 http://dx.doi.org/10. 1093/europace/eus333
  • [2] Potpara TS, Lip GYH. Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract. 2011; 65(4): 446-57. PMid:21219558 http://dx.doi.org/10.1111/j.1742-1241. 2010.02618.x
  • [3] Mugmon M. Atrial flutter with aberrant conduction in a patient taking amphetamine salts and caffeine. J Community Hosp Intern Med Perspect 2012 Jan 26;1(4). doi: 10.3402/jchimp.v1i4.10663. Print 2011.
  • [4] Ghuran A, Nolan J. The cardiac complications of recreational drug use. West J Med. 2000; 173(6): 412-15. PMid:11112762 http://dx.doi.org/10.1136/ewjm.173.6.412

New onset atrial fibrillation due to amphetamine use in a young patient

Year 2021, Volume 3, Issue 1, 45 - 49, 28.02.2021

Abstract

The Food and Drug Administration (FDA) label for amphetamine gives warning of serious cardiovascular events and risk of sudden death in patients with structural heart disease or other serious cardiac conditions. Literature review was unrevealing for linkage of amphetamine stimulants to atrial fibrillation specifically. Additionally, recreational use of amphetamines can cause electrical instability of the myocardium potentially leading to arrhythmias, although this is more typical in the setting of an underlying structural heart defect. We must rely on the diligence of the practitioner to evaluate all possible causes for a new onset arrhythmia, and possibly specifically ask about the off label use of these medications. There is clear documentation in the literature regarding myocardial infarction, stroke, and sudden death in adults using CNS stimulants. However, there is little data regarding specific arrhythmias, including atrial fibrillation, using these medications. Further studies need to be developed to assess the relationship between stimulant medications and atrial fibrillation, as well as guidelines for prescribing these medications to patients who may already be at risk for developing atrial fibrillation based on personal or family history.

References

  • [1] Wilke T, Groth A, Mueller S, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Eurospace. 2012; 15(4): 486-93. PMid:23220354 http://dx.doi.org/10. 1093/europace/eus333
  • [2] Potpara TS, Lip GYH. Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract. 2011; 65(4): 446-57. PMid:21219558 http://dx.doi.org/10.1111/j.1742-1241. 2010.02618.x
  • [3] Mugmon M. Atrial flutter with aberrant conduction in a patient taking amphetamine salts and caffeine. J Community Hosp Intern Med Perspect 2012 Jan 26;1(4). doi: 10.3402/jchimp.v1i4.10663. Print 2011.
  • [4] Ghuran A, Nolan J. The cardiac complications of recreational drug use. West J Med. 2000; 173(6): 412-15. PMid:11112762 http://dx.doi.org/10.1136/ewjm.173.6.412

Details

Primary Language English
Subjects Medicine
Journal Section Research Articles
Authors

Muammer KARAKAYALI> (Primary Author)
KARS HARAKANİ DEVLET HASTANESİ
0000-0001-7385-120X
Türkiye


Timor OMAR>
Kars Harakani Devlet Hastanesi
0000-0002-2481-0505
Türkiye

Publication Date February 28, 2021
Application Date January 13, 2021
Acceptance Date February 24, 2021
Published in Issue Year 2021, Volume 3, Issue 1

Cite

APA Karakayalı, M. & Omar, T. (2021). New onset atrial fibrillation due to amphetamine use in a young patient . Sabuncuoglu Serefeddin Health Sciences , 3 (1) , 45-49 . Retrieved from https://dergipark.org.tr/en/pub/sshs/issue/60508/860613